drugset / Trial / NCT00139659

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

NCT00139659

Phase 3 Completed 288 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Asthma

Timeline

Start
2003-01
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Inhaled
Comparator Insulin Protein / enzyme biologic Subcutaneous